Fusion Pharmaceuticals Inc. (FUSN) Financials

FUSN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 253.4 million 64.9 million
2023-06-30 268.3 million 65.3 million
2023-03-31 266.6 million 65.7 million
2022-12-31 219.1 million 56.8 million

FUSN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -19.3 million 3.0 million
2023-06-30 -20.3 million 3.0 million
2023-03-31 -26.7 million 3.1 million
2022-12-31 -20.3 million 2.8 million

FUSN Net Income

No data available :(

FUSN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 191.3 million - 18.0 million
2023-06-30 198.1 million - 16.1 million
2023-03-31 221.2 million 34.4 million 15.7 million
2022-12-31 186.6 million 34.2 million 6.0 million

FUSN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 69.1 million
2023-06-30 66.3 million
2023-03-31 53.8 million
2022-12-31 44.8 million

FUSN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 473000 14.6 million 6.8 million -
2023-06-30 710000 19.0 million 7.8 million -
2023-03-31 1.2 million 15.9 million 9.0 million -
2022-12-31 950000 17.6 million 7.0 million -

FUSN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.0 million 1.0 million
2023-06-30 34000 931000
2023-03-31 28000 15.9 million
2022-12-31 140000 17.6 million

FUSN

Price: $21.45

52 week price:
2.31
21.55

Earnings Per Share: -1.45 USD

P/E Ratio: -6.94

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 14300

Market Capitalization: 1.8 billion

Links: